Inhite Ventures

Navigare Ventures is an early-stage investor specialized in science-driven companies. Through our investments, we strengthen the industrial and societal impact of research, as well as the long-term financial capacity of our owners, Wallenberg Investments AB. Our core investment themes within deep tech are underpinned by our knowledge and network in a number of scientific fields and industries. These include advanced computing and quantum technologies, synthetic biology and bio innovation, advanced materials and nano technology as well as data-driven life science. We are long term investors - Seed and Series A and beyond - and form deep and lasting partnerships with founders and entrepreneurs. Our extensive industrial and scientific networks gives us the opportunity to provide capital, network, and know-how to transform promising science start-ups into successful companies. Who we are Navigare Ventures, based in Stockholm, is a fully owned subsidiary of Wallenberg Investments AB. We are a team of scientists, industrialists and entrepreneurs who understand the challenges of turning cutting-edge technologies to successful ventures. As part of the Wallenberg ecosystem, our returns fuel the next generation of scientific advancement through research funding from the Wallenberg Foundations to Swedish universities. What we are looking for We partner with experienced entrepreneurial teams that combine scientific excellence with strong business acumen. In this respect, your company should have a unique offering based on a profound understanding of your scientific or technological field and its market and industrial environment. You should also be capable of demonstrating the viability and commercial potential of your product by engaging with real customers. You are raising capital to scale the R&D, production, marketing, and sales capabilities of your company. Our investment philosophy We only invest in companies we understand. While this is an important general principle in any investment activity, it is even more important when making early-stage investments in new technology. If we don’t understand your science, we won’t understand what experts tell us about the value chain and how it works, or what the competitive landscape looks like. And most importantly, we won’t be able to help you develop your strategy and navigate through the challenges of deep-tech start-ups. So, when preparing a meeting with us, don’t put too much emphasis on future revenue projections. That’s important too, in due time. But first, be prepared for long sessions in front of a whiteboard, explaining to us how your material, algorithm, or antibody functions. We don’t need to understand all the equations, but we need to get the heuristics. We are scientists at heart, eager to learn, and we carry a deep conviction that the world is fundamentally understandable. Core investment themesAdvanced computing and quantum technologies: Digitization and automation deepens in industry and society, driven by breakthroughs in computing and AI. Our focus includes improving existing technologies as well as finding completely new platforms in AI and other areas of applied mathematics as well as in novel computer architectures, communication technology, hardware and design. Synthetic biology and bio innovation: Synthetic biology and bio innovations contribute to a more sustainable society. Companies in this field often combine principles of biology, engineering, and computer science for the development of new biological products and manufacturing methods. Advanced materials and nano technology: New materials and nanoscale technology enable disruptions with the potential to benefit numerous existing industries. From quantum materials to biomaterials and biologically inspired nanostructures, we look for the most promising technology platforms in the field. Data-driven life science: Combining digital technology and data with life science drives scientific understanding and enables novel products. Our focus is on data-driven methods to increase personalization and precision of medical interventions, accelerate product development, digitalize care among other advancements.

We support inspiring change-makers in healthcare. W Health Ventures is a Boston-based venture capital firm focused on helping entrepreneurs build the future of healthcare delivery. Founded by serial technology entrepreneur, investor, and philanthropist Sunil Wadhwani, W Health invests in early-stage companies that address critical unmet healthcare needs leveraging technology and AI in the US and India. The W Health team and advisory network comprise seasoned investors, physician leaders, technology experts, and healthcare operators in the US and India. Our Vision The healthcare system is broken across the world. This has created large unmet patient needs. W Health Ventures aims to solve critical challenges faced by people due to lack of access, lack of awareness and poor-quality healthcare. Our Mission To touch 100 million lives through the enterprises we help fund and grow

SeaX Ventures is a venture capital fund investing globally in early-stage companies with groundbreaking “exponential” technologies. We support visionary entrepreneurs across the world on their journeys to build great companies. We invest everywhere In the U.S. In Southeast Asia. Everywhere that founders are working on great ideas, we’ll be there. Centered on South East Asia expansion Our LPs consist of a few of the largest corporations in the region. We work with them strategically by making connections to the innovative entrepreneurs in whose startups we invest. That way, both our portfolio companies and our corporate partners benefit. Our unique 3As approachAccess: We provide our LPs access to deal flow globally with a focus on the U.S. and Asia. Accelerate: We leverage the platforms and networks of our sister company (RISE) which has over 2000+ startup alumni across the U.S. and Asia and several hundred corporate partners. Advantage: Our LPs are top multinational corporations and family offices. Collectively, we are a network of entrepreneurs, business partners, and co-investors. Bridging Silicon Valley and Asia Our knowledge of markets in both the US and Asia empowers us to identify and assist founders building audacious companies. Our focus is deep-tech We focus on exponential technologies that can transform societies and help countries achieve high levels of economic progress. So far, we’ve invested in Web3, biotech, advanced materials, and AI but we are certainly not limited to those areas. We’re also looking to support groundbreaking companies in agriculture, space, robotics, and more. Healthcare / Biotech Web3 / Crypto Material Science / Nanotechnology Artificial Intelligence Hardware / Robotics Foodtech

Like Benjamin Franklin knotting a key to a kite in a lightning storm, today’s AI researchers are unlocking technology that is reshaping our world. From quantum neural networks and transformers for NLP, to AI for drug discovery, the path to future innovations and commercialization is charted by a small subset of the global technology talent pool, the elite AI researchers. Coalescing around the pioneers of AI, including Toronto’s “godfather of deep learning” Geoffrey Hinton, this AI talent pool has laid the foundations for innovation and rapid commercialization. Radical is both a product of the Canada AI ecosystem and one of its architects. Radical founders Jordan Jacobs and Tomi Poutanen helped co-author the world’s first national AI strategy and conceived of and co-founded the Vector Institute for Artificial Intelligence, alongside Geoffrey Hinton, Ed Clark and others in 2017. Vector began with 8 faculty and is now home to over 1700 of the world’s top AI researchers. Before Radical, Jordan and Tomi founded Milq in 2011 and then spun-out Layer 6 AI in 2016, an AI prediction platform company later acquired by TD Bank, where they became co-Chief AI Officers. As founders, ecosystem builders and investors, the Radical team has played an active role in nurturing the next generation of AI innovation and commercialization. Just as Thomas Edison would build upon Franklin’s discoveries, now is the moment to capitalize on the opportunity afforded by innovations in AI. Every facet of our economy and lives stand to benefit from breakthroughs in AI. Like today’s electrical grid, AI will soon power nearly every human interaction with technology. Lightning to light bulb. That is the transformative moment we are investing in.

LiquidMetal Ventures is a newly established venture capital fund based in Boston, aiming at investing in early-stage (Seed, Angel, and pre-A round) in a minority group, particularly deep-tech startups. LiquidMetal Ventures is based on deep-tech start-up communities and has a unique advantage in reaching out to ‘off-the-market’ early-stage deals and cooperating with peer VC funds tightly to reduce the risk, overall a high return could be expected. LiquidMetal Ventures focuses on biotech and healthcare, carbon neutrality, AI and data, infrastructure, and consumer tech. There is a huge tide of startups among Boston entrepreneurs in the US on the way. We would like to be the first to check VC with the founders. Investment FocusBioTech Medical Device Sustainability AI & Data Science Advanced Energy Technology Robotics & Advanced Manufacturing

Through empowering equity investment and in-depth industry research with capital support, we provide comprehensive support including strategy, funding, compliance, product, sales, branding and team building. We are committed to long-term partnership based on mutual benefit and trust, advancing together to promote project growth and build a lifelong career platform across professional cycles. We focus on innovative finance, internet information, AI, intelligent manufacturing, healthcare and other fields. As of November 2024, we have invested in 9 projects, with typical cases like 'Kaipanla APP', etc. We uphold the concept of openness and inclusiveness, respect diverse cultures, advocate innovative thinking and encourage an open mindset. We build a positive work atmosphere through flat management, enabling colleagues to find room for growth and value realization.